 - Patients with a history of prior treatment with an anti-programmed cell death PD 1 antibody, CD137 agonist or other immune activating therapy such as anti-CD 40 antibody are excluded unless 5 half-lives of the agent minimum of 8 weeks have intervened since the therapy; patients who have received prior vaccine therapy are eligible 